Found 62 matching trials
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
PHASE1This is a phase I single center dose escalation study with an extension at ...
Location
Masonic Cancer Center, University of Minnesota
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
PHASE1Primary Objective:
• To evaluate the safety and tolerability of cAd3-EBO-S...
Location
Oklahoma Blood Institute (OBI)
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
PHASE2To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Location
University of Perugia
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
PHASE2The immune system has offensive and defensive capacities. In bone marrow tr...
Location
Katholieke Universiteit Leuven
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure
PHASE2Prognosis of patients with graft failure is dismal, and re-transplantation ...
Location
Multiple Locations
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
PHASE1The goal of this clinical trial is to learn if patients who have brittle ty...
Status
Enrolling By Invitation
Location
Stanford University
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
PHASE2Phase II clinical trial to assess the efficacy of donor regulatory enriched...
Location
José Antonio Pérez Simón
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant
PHASE1This phase I trial studies the side effects and best dose of donor regulato...
Location
Stanford University Hospitals and Clinics
Multiple Donor Treg DLI for Severe Refractory Chronic GVHD
PHASE1This is a INTERVENTIONAL TRANSPLANTATION STUDY WITHOUT DRUGS.
The INTERVEN...
Location
University Hospital St. Orsola-Malpighi Polyclinic
The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
N/AThe cause of Inflammatory Bowl Disease (IBD) is not known, but studies from...
Location
Child and Family Research Institute